Skip to content

Serotonin: all studies

Page 338 of 400: studies 3,371 to 3,380 of 3,999, newest first. Back to the serotonin overview

Research

MDMA enhances emotional empathy and prosocial behavior

Social Cognitive and Affective Neuroscience October 4, 2013 Cédric M. Hysek, Yasmin Schmid, Linda D. Simmler et al. 356 citations

3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') releases serotonin and norepinephrine. MDMA is reported to produce empathogenic and prosocial feelings. It is unknown whether MDMA in fact alters empathic concern and prosocial behavior. We investigated the acute effects of MDMA using the Multifaceted Empathy Test (MET), dynamic Face Emotion Recognition Task (FERT) and Social Value Orientation...

Broadband Cortical Desynchronization Underlies the Human Psychedelic State

Journal of Neuroscience September 18, 2013 Matthew J. Brookes, David Errtizoe, Ben Sessa et al. 501 citations

Psychedelic drugs produce profound changes in consciousness, but the underlying neurobiological mechanisms for this remain unclear. Spontaneous and induced oscillatory activity was recorded in healthy human participants with magnetoencephalography after intravenous infusion of psilocybin—prodrug of the nonselective serotonin 2A receptor agonist and classic psychedelic psilocin. Psilocybin...

Sex-dependent effects of early maternal deprivation on MDMA-induced conditioned place preference in adolescent rats: possible neurochemical correlates.

Toxicology September 6, 2013 Alvaro Llorente‐berzal, Carmen Manzanedo, Manuel Daza‐losada et al.

The early neonatal stage constitutes a sensitive period during which exposure to adverse events can increase the risk of neuropsychiatric disorders. Maternal deprivation (MD) is a model of early life stress that induces long-term behavioural and physiological alterations, including susceptibility to different drugs of abuse. In the present study we have used the conditioned place preference...

DOI: 10.1016/j.tox.2012.12.003 (opens in new tab) Full text (opens in new tab) MDMA Adolescence Cb1 receptor Conditioned place preference +2

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation

British Journal of Pharmacology September 6, 2013 Cédric M. Hysek, Yasmin Schmid, Anna Rickli et al. 7 citations

We greatly appreciate the comments offered by Drs Rolle, Takematsu and Hoffman and the opportunity to put our work into a wider perspective. We share the view that our work does not reflect the clinical situation but rather provides a proof of mechanism study, which aims to help to translate preclinical findings (Sprague et al., 2005) into the clinic. As we noted in the discussion of our work...

microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus

The International Journal of Neuropsychopharmacology September 1, 2013 Richard M. O'Connor, Susan Grenham, Timothy G Dinan et al.

Abstract: Early-life stress is a main contributory factor to the onset of depression. Treatments remain inadequate and as such, a large unmet medical need for novel therapeutics remains. Impeding advancement is the poor understanding of the molecular pathology. microRNAs (miRNAs) are novel regulators of gene expression. A paucity of information regarding their role in depressive pathology and...

NBOMe — a very different kettle of fish …

The Medical Journal of Australia September 1, 2013 David Caldicott, Stephen Bright, Monica J Barratt

NBOMe — a very different kettle of fish . . . TO THE EDITOR: We are concerned that recent media reports about a 17-year-old Sydney boy who died after allegedly consuming 25Bor 25I-NBOMe might lead to an increase in the incidence of NBOMe toxicity among patients presenting to emergency departments. NBOMe was reported to be available online for as little as $1.50 per tablet.1 The subsequent media...

Psychedelics and Mental Health: A Population Study

PLoS One August 19, 2013 Teri Suzanne Krebs, Pål-ørjan Johansen 338 citations

BACKGROUND: The classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelics have been used in the Americas for thousands of years. Over 30 million people currently living in the US have used LSD, psilocybin, or...

PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS

Journal of Neurology, Neurosurgery, and Psychiatry August 6, 2013 R. Carhart-Harris 17 citations

After completing an undergraduate degree in Psychology in 2003, Robin studied psychoanalysis at Masters level, receiving his MA in 2004. In 2005, Robin began a four year PhD in Psychopharmacology at the University of Bristol. Working for Professor David Nutt and Dr Sue Wilson, Robin9s thesis focused on sleep and serotonin function in ecstasy users. Robin conducted a clinical study involving...

Neurotoxicity of Methamphetamine and 3,4-methylenedioxymethamphetamine

Life Science July 24, 2013 Laura E. Halpin, Stuart A. Collins, Bryan K. Yamamoto 195 citations

Amphetamines are a class of psychostimulant drugs that are widely abused for their stimulant, euphoric, empathogenic and hallucinogenic properties. Many of these effects result from acute increases in dopamine and serotonin neurotransmission. Subsequent to these acute effects, methamphetamine and 3,4 methylenedioxymethamphetamine (MDMA) produce persistent damage to dopamine and serotonin nerve...

Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.

Cell biochemistry and function July 2013 Melissa Cavalheiro Tourino, Edson Mendes De Oliveira, Luziane Potrich Bellé et al.

Indoleamine 2,3-dioxygenase (IDO) is an interferon-γ (IFN-γ)-induced tryptophan-degrading enzyme, producing kynurenine (KYN) that participates in the mechanism of tumor immune tolerance. Thus, IDO inhibition has been considered a strategy for anticancer therapy. The aim of this study was to identify whether the metabolites originated from the competitive routes of tryptophan metabolism, such as...

DOI: 10.1002/cbf.2980 (opens in new tab) Full text (opens in new tab) Immune escape Kynurenine pathway Tolerance Tryptophan metabolism +1